Showing 401 - 420 results of 646 for search '"metabolic syndrome"', query time: 0.08s Refine Results
  1. 401
  2. 402
  3. 403

    Biochemical characteristics, nutrient intakes, and chronic disease risk according to the dietary fat energy ratio in middle-aged Korean: a cross-sectional study using data from the... by Ga-Hyeon Jeong, Sook-Bae Kim

    Published 2024-12-01
    “…The risk of diabetes mellitus and metabolic syndrome was highest in the deficient group, and the risk of liver cirrhosis was highest in the excessive group. …”
    Get full text
    Article
  4. 404

    Effect of Intermittent Fasting Diet on Glucose and Lipid Metabolism and Insulin Resistance in Patients with Impaired Glucose and Lipid Metabolism: A Systematic Review and Meta-Anal... by Xiaojie Yuan, Jiping Wang, Shuo Yang, Mei Gao, Lingxia Cao, Xumei Li, Dongxu Hong, Suyan Tian, Chenglin Sun

    Published 2022-01-01
    “…Intermittent fasting diets have certain therapeutic effects on blood glucose and lipids in patients with metabolic syndrome and significantly improve insulin resistance. …”
    Get full text
    Article
  5. 405

    Genetic variability in the cholecystokinin A receptor affects lipid profile and glucose tolerance in patients with polycystic ovary syndrome by Eva Drnovsek, Mojca Jensterle, Katja Goričar, Sara Redenšek, Andrej Janež, Irina Milisav, Vita Dolžan

    Published 2022-06-01
    “…Healthy controls with at least one polymorphic CCKAR rs1800857 C allele were less likely to have a high metabolic syndrome burden (p = 0.029). Conclusions Genetic variability in CCKAR affects lipid profile and post-load glucose levels in patients with PCOS and is associated with metabolic syndrome burden in healthy young women. …”
    Get full text
    Article
  6. 406

    A journey into a Mediterranean diet and type 2 diabetes: a systematic review with meta-analyses by Demosthenes Panagiotakos, Katherine Esposito, Paolo Chiodini, Maria Ida Maiorino, Giuseppe Bellastella, Dario Giugliano

    Published 2015-08-01
    “…A random-effect model was used to pool data.Participants Adults with or at risk for type 2 diabetes.Interventions Dietary patterns that described themselves as using a ‘Mediterranean’ dietary pattern.Outcome measures The outcomes were glycaemic control, cardiovascular risk factors and remission from the metabolic syndrome.Results From 2824 studies, 8 meta-analyses and 5 RCTs were eligible. …”
    Get full text
    Article
  7. 407

    Metabolic Profile in a Cohort of Young Sicilian Patients with Klinefelter’s Syndrome: The Role of Irisin by Stefano Radellini, Valentina Guarnotta, Vincenzo Sciabica, Giuseppe Pizzolanti, Carla Giordano

    Published 2022-01-01
    “…KS is characterized by early development of metabolic syndrome and in particular by alterations of the glucose metabolism, independently of testosterone levels serum and BMI. …”
    Get full text
    Article
  8. 408

    Resistant Hypertension and Obstructive Sleep Apnea in the Primary-Care Setting by M. Demede, A. Pandey, F. Zizi, R. Bachmann, M. Donat, S. I. McFarlane, G. Jean-Louis, G. Ogedegbe

    Published 2011-01-01
    “…Data emanated from Metabolic Syndrome Outcome Study (MetSO), a study investigating metabolic syndrome among blacks in the primary-care setting. …”
    Get full text
    Article
  9. 409

    Prevalence and association of non-alcoholic fatty liver disease and insulin resistance among non-diabetic obese, overweight, and metabolically obese normal-weight adult patients at... by Samik Pramanik, Jimmy Barua, Lokanathan V, Sharmistha Roy

    Published 2025-02-01
    “…Background: Worldwide, the incidence of obesity, overweight, and metabolic syndrome is dramatically increasing. Non-alcoholic fatty liver disease (NAFLD) is associated with both obesity/overweight and metabolic syndrome. …”
    Get full text
    Article
  10. 410

    Adiponectin in Cardiovascular Inflammation and Obesity by Tamar R. Aprahamian, Flora Sam

    Published 2011-01-01
    “…It is becoming increasingly evident that obesity is linked to many proinflammatory and obesity-associated cardiovascular conditions (e.g., metabolic syndrome, acute coronary syndrome, and congestive heart failure). …”
    Get full text
    Article
  11. 411

    <i>In Vitro</i> and <i>In Vivo</i> Interventions Reveal the Health Benefits of Levan-Type Exopolysaccharide Produced by a Fish Gut Isolate <i>Lactobacillus reuteri</i> FW2 by Waqar Ahmad, Anam Nasir, Satya Prakash, Azam Hayat, Mujaddad ur Rehman, Shazia Khaliq, Kalsoom Akhtar, Munir Ahmad Anwar, Nayla Munawar

    Published 2025-01-01
    “…Therefore, in this study, we conducted in vitro and in vivo experiments, concerning intestinal cell integrity and metabolic syndrome, to assess the therapeutic potential of levan derived from <i>Lactobacillus reuteri</i> FW2. …”
    Get full text
    Article
  12. 412

    ER Stress and Lipid Metabolism in Adipocytes by Beth S. Zha, Huiping Zhou

    Published 2012-01-01
    “…Adipocytes are one of the major cell types involved in the pathogenesis of the metabolic syndrome. Recent advances in dissecting the cellular and molecular mechanisms involved in the regulation of adipogenesis and lipid metabolism indicate that activation of ER stress plays a central role in regulating adipocyte function. …”
    Get full text
    Article
  13. 413

    The risk factors of dyslipidaemia and obesity incidence: Result from 2019 cohort study of NCDs in Bogor City by Dwi Cantika Aulia, Ekayanti Ikeu, Sudikno Sudikno

    Published 2025-01-01
    “…Dietary intake and lifestyle factors contribute to dyslipidaemia and obesity, both of which elevate the prevalence of metabolic syndrome. This study utilized secondary data and using multinomial logistic regression analysis to investigate the influence of gender, education, calorie intake, carbohydrates, and fiber on dyslipidemia and obesity. …”
    Get full text
    Article
  14. 414

    Lipophagy: Connecting Autophagy and Lipid Metabolism by Rajat Singh, Ana Maria Cuervo

    Published 2012-01-01
    “…Defective lipophagy has been already linked to important metabolic disorders such as fatty liver, obesity and atherosclerosis, and the age-dependent decrease in autophagy could underline the basis for the metabolic syndrome of aging.…”
    Get full text
    Article
  15. 415

    PPARgamma-Dependent Control of Renin Expression: Molecular Mechanisms and Pathophysiological Relevance by Vladimir T. Todorov

    Published 2013-01-01
    “…Furthermore, I discuss the need for generating of additional transgenic animal models which are more appropriate with regard to the role of the PPARgamma-dependent regulation of the renin gene expression in human diseases such as arterial hypertension and metabolic syndrome.…”
    Get full text
    Article
  16. 416

    Nonalcoholic Fatty Liver Disease Cirrhosis: A Review of Its Epidemiology, Risk Factors, Clinical Presentation, Diagnosis, Management, and Prognosis by Bei Li, Chuan Zhang, Yu-Tao Zhan

    Published 2018-01-01
    “…With the growing epidemic of obesity and metabolic syndrome, nonalcoholic fatty liver disease (NAFLD) has become the most common cause of chronic liver disease worldwide and will become one of the leading causes of cirrhosis. …”
    Get full text
    Article
  17. 417

    Hyperglycemia and Endothelial Dysfunction in Atherosclerosis: Lessons from Type 1 Diabetes by Steven Daniel Funk, Arif Yurdagul, A. Wayne Orr

    Published 2012-01-01
    “…Some of this confusion derives from studies in type 2 diabetics where multiple components of metabolic syndrome show proatherosclerotic effects independent of underlying diabetes. …”
    Get full text
    Article
  18. 418

    Drug Therapy for Non-Alcoholic Steatohepatitis-Induced Liver Fibrosis by D. V. Garbuzenko

    Published 2022-01-01
    “…In current clinical recommendations, therapeutic measures in non-alcoholic fatty liver disease should include lifestyle change, body weight normalisation, NASH-associated liver fibrosis-specific drug therapy and treatment for metabolic syndrome-related diseases. Given a lack of approved antifibrotic therapies in NASH, several drugs have nevertheless demonstrated an adequate efficacy and safety in phase 3 clinical trials, also in compensated cirrhosis, which allows their practical validation in phase 4.Conclusion. …”
    Get full text
    Article
  19. 419

    Osteoprotegerin in Cardiometabolic Disorders by C. Pérez de Ciriza, A. Lawrie, N. Varo

    Published 2015-01-01
    “…Besides, other associated diseases such as obesity, hypertension, and metabolic syndrome, which are known cardiovascular risk factors, are also considered.…”
    Get full text
    Article
  20. 420

    Recent Advances in Potential Clinical Application of Ghrelin in Obesity by Christine Delporte

    Published 2012-01-01
    “…Ghrelin is involved in weight regulation, obesity, type 2 diabetes, and metabolic syndrome. Furthermore, a better understanding of ghrelin biology led to the identification of molecular targets modulating ghrelin levels and/or its biological effects: GOAT, ghrelin, and GHS-R1a. …”
    Get full text
    Article